{"id":"W4417004955","doi":"10.1182/blood-2025-1024","title":"Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Essential thrombocythemia; Anagrelide; Myelofibrosis; Calreticulin; Hematology; Thrombocytosis; Thrombopoietin receptor; Polycythemia vera; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004466544,0.0003271976,0.0005806811,0.000141353,0.0002086186,0.0003634617,0.0002882663,0.0005329369,0.001090725],"category_scores_gemma":[0.0006056934,0.000116364,0.0005375645,0.0002309322,0.0001914868,0.0002606478,0.0001499078,0.001064938,0.000287223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005853153,"about_ca_system_score_gemma":0.0004516838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005509468,"about_ca_topic_score_gemma":0.0007696188,"domain_scores_codex":[0.9998299,0.00006234271,0.00001881182,0.00003058966,0.00003040478,0.0000278657],"domain_scores_gemma":[0.9996651,0.0000701977,0.00009555841,0.000023093,0.00003169044,0.0001142845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3391588,0.01235643,0.1006305,0.0008406619,0.001533874,0.001983086,0.0003102341,0.003245279,0.1062953,0.000418607,0.008700566,0.4245268],"study_design_scores_gemma":[0.1768011,0.4813706,0.2766505,0.0002001719,0.001652715,0.007319431,0.0001767634,0.008569793,0.02344742,0.0006312368,0.02310929,0.00007094978],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929895,0.003645184,0.000332029,0.000314238,0.00004584638,0.0001296182,0.0005631871,0.00004755935,0.001932831],"genre_scores_gemma":[0.9982731,0.0005000975,0.0001834106,0.0002365138,0.00002917651,0.00005043749,0.0004272481,0.000004230246,0.000295825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001090725,"threshold_uncertainty_score":0.004246771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006471341317987652,"score_gpt":0.2467173859262837,"score_spread":0.240246044608296,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}